WeedLife News Network

Some cannabis marketers look down on digital advertising, preferring the idea of building their brands without having to pay for clicks. Others believe that digital cannabis advertising isn’t even allowed.

Both notions are incorrect. First, brands that use digital advertising will be seen by many more eyeballs than purely organic marketing. Second, many forms of digital cannabis advertising are legally compliant in any state, and in some ways, these ads are actually less restrictive than the traditional advertising methods brands have frequently pursued instead. 

While advertisers and Hollywood-types have consistently focused on millennials and Gen-Z over the past few years, it turns out that the cannabis industry may want to turn its attention to another group of potential consumers — senior citizens. According to a report from NBC news, baby boomers in the United States, especially men, have seen their cannabis use rise in the past few years. 

According to NBC News, the numbers come from a new report out in the Annals of Internal Medicine, reflecting changing attitudes towards the drug throughout the United States. The study’s co-author Bill Jesdale, an assistant professor of population and quantitative health science at the University of Massachusetts Medical School in Worchester, told NBC News that more people are accepting of and open to using cannabis now more than ever.

According to Jesdale, cannabis use among older adults is not only increasing in states where the drug is legal, but it is also on the rise in states where prohibition is still in effect.

“It seems that something has happened to the country as a whole,” Jesdale told NBC News.

Jesdale’s study collected survey data from a three year period from 2016 to 2018. According to the report, researchers reviewed cannabis use in over 170,000 adults over the age of 55; two lived in 19 different states and two territories throughout the country. The results found that men between the ages of 60 and 64 were more likely than most to use marijuana. In fact, according to the study, over 12 percent of men in that age bracket used cannabis in the past 30 days when asked in 2018, which was up from around 8 percent who did so in the same period when asked in 2016.

What Will These Pot Stocks to Watch Look Like in the Long Term?

The governor’s comments join a fierce opposition wave against medical marijuana legalization in Nebraska.

A voter-approved initiative to legalize medical cannabis in Nebraska will appear on the November ballot, but marijuana shouldn’t even be labeled a medicine, according to Gov. Pete Ricketts. The comments represent a fierce opposition emerging in Nebraska against legalization.

“There is no such thing as medical marijuana,” Ricketts said at a press conference Monday. “This is not something that would be prescribed by a doctor. It’s not going to be distributed through a pharmacy. These are dispensaries that would be in your communities.”

Ricketts has spoken out against medical cannabis on multiple occasions and claimed that in legalized states, people “show up to work stoned” and cause a greater number of accidents.

“This is not a benign thing, this is a dangerous thing,” he added.

America’s decades-long war on drugs disproportionately harmed minorities. Now, it seems that decriminalization of marijuana hasn’t leveled the playing field.

Black men are 12 times more likely than white men to spend time incarcerated in the United States. College enrollment for black men has declined since the 1986 Anti-Drug Abuse Act went into effect.

I am a scholar of public policy. In my book, “From Criminalizing to Decriminalizing Marijuana: The Politics of Social Control,” I aim to provide a historic overview of marijuana legislation and its impact on minorities.

Unequal easing

Today, some drug laws related to marijuana are easing. Twenty five states have introduced decriminalization reforms, with 11 states allowing adult recreational use. Such reforms directly impact adults 21 years of age and older, but they also have indirect effect on younger Americans.

Even though marijuana is still illegal for people under 21, evidence is emerging that decriminalization is increasing the number of kids who consume weed illegally.

Although California is viewed as a liberal paradise – especially regarding cannabis laws – the way this state regulates CBD is still incredibly limited and regressive.

California has the oldest and largest legal cannabis market in the world. Medical marijuana has been legal in the state for 24 years now, recreational is legal, and you can easily find flower and other high-THC products in most localities. However, when it comes to CBD (cannabidiol), California dispensaries need a special license to sell hemp flower, it’s illegal to infuse CBD in edibles, and a bill is on the table that would prohibit anyone under 21 years old from buying any it.

Why the discrepancy when CBD is non-psychoactive and federally legal?

Over two decades of medical marijuana

Back in 1996, the Golden State became the first to legalize the use of medical marijuana. It was uncharted territory, and putting Prop 215 – The Compassionate Use Act, into practice would be no easy task; but the main objective was “to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraines or any other illness for which marijuana provides relief.”

And the bill really meant ANY illness. This drew a lot of criticism, with many lawmakers believing that cannabis should only be prescribed for a very limited list of predetermined conditions. However, lawmakers are not doctors or scientists and are in no position to make assumptions on the therapeutic potential of cannabis. Questions of medication, treatments, and prescriptions should handled by healthcare practitioners and their patients.

The last two decades have brought bi-racial athletes, politicians, scientists, entrepreneurs, and more to the forefront. On August 19th we nominated Senator Kamala Harris, the first Vice President of Jamaican and Indian heritage. There is an excitement in the air, young women see themselves in Kamala Harris and think "If she can, I can". Which brings us to our interview with Socrates Rosenfeld, his father is a Greek Cypriot, his adopted stepfather is Jewish American and his mother grew up in Indonesia, of Egyptian and Sumatran roots.

I would say Socrates is the International Food Court of genetics. Socrates is the CEO of  Jane Technologies, Inc., a retail software company that created the leading online cannabis marketplace, has announced the launch of two new e-commerce modules designed to deepen brand relationships with consumers while promoting local dispensary sales. When I first met Socrates and Howard Hong up in San Francisco over 4 years ago, I saw two young men who "had it", I saw the future of Asian Americans in cannabis and who was going to lead the way in innovation and entrepreneurship.  Rosenfeld's career started in the US Army and he left with the rank of Commander, to the world of finance.

Rosenfeld's heritage I believe gave him the skills to build bridges wherever he went and to build businesses that encapsulate that multicultural heritage. It is my honor to present our Q&A with Socrates Rosenfeld, CEO of Jane Technologies.

As a child of two cultures, how did you navigate your place in the world by using that duality? (This question is about children who come from parents with diverse backgrounds and cultures, as in Tiger Woods, Kamala Harris, Colin Powell who had Jamaican and Scottish ancestry)

Socrates Rosenfeld: Growing up in a multicultural home with generations of mixed heritage, I came to understand that connection transcends language, race, or religion. I didn't have to travel around the world to be exposed to different cultures -- they were under my roof. Indonesian, Greek, American, Muslim, Christian, Jewish, and even Atheist. Naturally, there were clashes, but ultimately everyone was able to connect on the commonalities that tie us all together as human beings.

I am fortunate to live in a state that recognizes, to a degree, the medical benefits of cannabis (marijuana).  It effectively eases my  symptoms, unlike any of the various side-effect-laden, addictive drugs prescribed for my conditions.

The program, however, is falling short of its potential.

The two Compassionate Care Centers in Sussex have severe supply problems that limit their effectiveness for patients.  They too often have none of the product that a patient relies on, be it dried cannabis flower, concentrates, or edibles.  One of the two centers rarely has THC-containing product other than on their weekly delivery day; the other is more reliable but runs out at times during the day.  The product availability within categories is inconsistent. 

Cannabis varieties are known as strains; strains differ in their cannabinoid and terpene components (it’s not all about THC) and have very different effects and efficacy.  Patients learn which strains help them - it’s a wonderful discovery! 

The problem is that the availability of the strains at the CCCs is hit or miss; we often have to experiment or settle for a suboptimal medicine.  There are also differences in product offerings across CCCs.  Patients often must visit multiple centers to obtain the products they need.  Imagine having to visit one pharmacy for antibiotics and a different one for cough medicine.

Indonesia made a splash when a decree from earlier this year declaring cannabis a “medical plant” in the eyes of the government officially got on the public’s radar. Now, the Agricultural Ministry in Indonesia is revising this decree, as cannabis is still illegal in Indonesia with no legalization in sight. 

The proclamation originally went viral via an Instagram post from the Nusantara Marijuana Network (LGN), a group that fights for cannabis legalization and advocacy in Indonesia. According to this degree, cannabis has been considered a medical plant since 2006 by the federal government; this just hasn’t necessarily been public knowledge.

“The decree will be revised soon, after we coordinate with the National Narcotics Agency [BNN], the Health Ministry and the Indonesian Institute of Sciences [LIPI],” the ministry’s vegetable and medicinal plant director, Tommy Nugraha, said in a statement on Saturday. “Marijuana’s inclusion on the medicinal plant list means that it can only be used for research, as stipulated in Article 67 of Law No. 13/2020 on horticulture. Currently, we record no legal marijuana farmers in Indonesia.”

Thus, the “medical plant” designation is very ironic, considering the strict laws against cannabis Indonesia still clings to and doesn’t show signs of giving up. As recently as 2015, a court in Bali sentenced both an Indonesian man and an Australian man who shared a joint to one year in prison. Collectively, the two had less than a gram between them in the joint. And in 2017, a man was sentenced to eight months in jail and a fine equivalent to $69,000 for growing 39 plants in order to extract oil for treating his sick wife.

The Status of Cannabis in Indonesia

Currently, in Indonesia, cannabis is still considered a type-1 narcotic, meaning it is on the same level as cocaine and opium according to national drug laws. Possession of cannabis carries up to 12 years in prison or a large fine. Those who produce or traffic cannabis could serve up to 15 years in prison and pay an even harsher fine.

CBD is a pharmacological treasure trove for pet wellness, with claims that it can help cure seizures, appetite loss, nausea, pain relief, inflammation, skin allergies, osteoarthritis, and anxiety. And the evidence isn't just anecdotal. There are over 100 research papers published to support a promising future for CBD as a treatment for dogs and other animals. 

Unfortunately, while CBD holds excellent opportunities to make our dogs lives better, the laws are impeding research and forbidding practicing veterinarians to prescribe CBD or even recommend it. 

The big obstacles

The crux of the problem lies in the Schedule 1 classification of marijuana in the federal Controlled Substances Act ("CSA") as a drug "with no currently accepted medical use." Until marijuana legalizes, clinical trials remain scarce, and the American Veterinarian Medical Association (AVMA) won't approve the use of CBD. 

Marijuana's illegal status is holding back the cannabis industry from significant growth and breakthrough medical discoveries.

Another obstacle in product safety is the lack of FDA guidelines, even though it has been two years since the 2018 Farm Bill passed, allowing the cultivation of hemp.

If there’s one thing that the U.S. seems to enjoy, it’s health fads.

There has been no shortage of health-conscious trends that have made their way into the public eye only to become yesterday’s news in a matter of months.

Keto dieting, kale integration, juice cleansing, gluten avoidance, and even colonic hydrotherapy are just a few examples of health fads that seemed like they were going to change the world, only to quickly become a relic of their time.

This has led to CBD being considered a wonder drug by some and snake oil by others.

There’s no doubt that CBD is very much “in” right now.

The numbers back this up, looking at Statista’s list of CBD sales over the years: $108.1 million in 2014, $262.2 million in 2016, $512.7 million in 2018, and a projected $1.812 billion in 2022.

Virginia made history last week when the state Senate approved a bill that would stop police officers from pulling over and searching vehicles simply because they smell of cannabis. The bill is meant to help stop racial profiling against people of color. 

This is a big deal because Black folks are more than three times as likely to be arrested for cannabis, according to the ACLU and the data that has been gathered on cannabis use. In general, stop-and-search because of a cannabis smell is likely to involve stereotyping and impact minority groups negatively. 

“This is a small but important step to decriminalizing Black and brown bodies of being targeted by this longtime policing tool, which was really created by politicizing the war on drugs,” said Chelsea Higgs Wise, executive director of the nonprofit Marijuana Justice, regarding the possibility of passing this new bill. “The odor of marijuana is something that our undocumented community is anxious about because it’s life or death and separation from their families.” 

Cannabis Crime in Virginia

While cannabis decriminalization took effect in Virginia this past July, possession of more than an ounce can still result in a serious penalty, and having up to an ounce still results in a $25 fine. Thus, the negative impact tied to policing people of color is still there under this current system. 

“All of that has to stop to meet the full demand of legalization and fully, truly decriminalizing marijuana and Black and brown bodies in the eyes of the police,” Higgs Wise said regarding the change this bill could make. 

Athletes, this one is for you.

The CBD marketplace is robust with topicals that aid in recovery. From muscle tension post-exercise to pain in your hands and wrists caused by carpal tunnel, the power of cannabinoids to both reduce inflammation and pain is a game-changer. CBD is not the only cannabinoid coming to the rescue. Mounting research shows that its cousin cannabigerol or CBG holds efficacy when it comes to reducing pain, inflammation, and bringing relief. 

Topicals are one of the most popular methods of utilizing CBD in your daily routine. Here are 5 topicals great for whatever type of recovery your body may need.

Boost Nano Hydrogel from Beam

Boost, the Nano Hydrogel from Beam, is praised by athletes across the country, including their team's powerful influencer network members Danica Patrick, PGA golfer Billy Horschel, Matthew Fraser, and more. The water-based CBD is made with orange and citrus organic essential oils, so its scent is a light and pleasant one. Beam's proprietary nano CBD technology makes it one of the faster-absorbing topicals for consumers to date. 600 milligrams of CBD can be found in each bottle.

CBG Topical from Goodekind

Goodekind is a new CBD offering on the market that is a dream for post-workout recovery. The special part about this one? It is made with 300 milligrams of CBG, CBD's cannabinoid counterpart that offers loads of benefits from anti-inflammatory to pain relief. Goodekind's topical is also made using organic shea butter, beeswax, coconut oil, and essential oils. The company offers additional trust to consumers by including the complete lab reports for each batch, so you know what you're getting. Goodekind is also kicking back a portion of its profits, one-eighth to be exact, to human rights coalition initiatives across the U.S.

States with higher cannabis and e-cigarette vaping use were not tied to higher rates of the e-cigarette or vaping-association lung illness (EVALI) outbreak from last year, a new study found. In fact, most states with legal marijuana access were connected with a fewer number of EVALI cases on average compared to places where it remains illegal.

The study was published in the journal Addiction this week and corroborates previous reports that EVALI was most likely connected to vaping products purchased from informal sources, or on the black market.

Researchers examined data from the Centers for Disease Control and Prevention (CDC), which has confirmed more than 2,800 cases and 68 related deaths from the illness. When the CDC ended its investigation in February when no further EVALI outbreaks occurred, they determined vitamin E acetate was the culprit behind the illness. Often vitamin E acetate is a substance used on the black market to thin vaping liquids and sell products for higher profit margins.

“If e-cigarette or marijuana use per se drove this outbreak, areas with more engagement in those behaviors should show a higher EVALI prevalence,” study author Abigail Friedman said. “This study finds the opposite result.

“Alongside geographic clusters of high EVALI prevalence states, these findings are more consistent with locally available e-liquids or additives driving the EVALI outbreak than a widely used, nationally-available product.”

President Donald Trump is afraid of marijuana. He said so himself: In a campaign appearance in Wisconsin earlier this month, the president cracked a nervous “joke” with former Gov. Scott Walker, suggesting that cannabis-related ballot initiatives drove Democratic Party-minded voters to the polls.

From instituting new on-the-spot cannabis fines, to battling it out in court with the EU over the legality of CBD imports, France is quite busy right now, and the implications of its case could change cannabis laws throughout Europe.

Some countries make more sense in their slower acquiescence to accepting cannabis (and some have barely started the process at all). But many countries, particularly those of Western Europe, are gradually easing restrictions on cannabis use. This is not the case for France, which just instituted new fines for cannabis users, and is fighting the EU to restrict CBD imports that have any THC at all.

Cannabis in France

In France, it’s illegal to both use and possess cannabis. Unlike most countries, France doesn’t differentiate between personal use and trafficking, meaning the amount of cannabis a person is found with, and the decision of the prosecutor, are what define the circumstance and punishment. It is up to the prosecutor in a particular case to determine whether the offender should go unpunished, if they should enter treatment, or if they will proceed in the court system. A person charged can receive a fine of up to €3,750 as well as a year long prison sentence. This is increased to €75,000 and five years in prison if the offender endangered others while using.

In 2008, the ‘rapid and graduated’ policy began which stated that in clear-cut cases, offenders could possibly get away with just a warning and a treatment program, as well as a possible fine of €450 if the person is not addicted to cannabis (however that is defined).

In 2018, yet another new policy was introduced by the government in which fines could be given on-the-spot to cannabis users. It started as a test in smaller communities, until becoming national policy last month.

As possession and use are illegal and there’s no formal medical program, growing cannabis – for any reason – is illegal, and subject to the same fines and prison time as other cannabis crimes, depending on how the prosecutor deems the case.

Sales of recreational cannabis have broken $100 million for three months in a row in Oregon as the state continues to wrestle with the COVID-19 pandemic.

According to data from the Oregon Liquor Control Commission, which oversees marijuana sales, sales have been up since March, when the state went into lockdown to slow the spread of the virus.

That month total sales in Oregon were $84.5 million, 30% higher than March of 2019.

At the time, some business owners worried the March bump was temporary. But numbers show things have only gotten better, at least for some of the state’s cannabis retailers.

In April, total sales went up 5.7% to $89.7 million which was 44% over the previous April.

Todd Zinicola is pretty sure it’s the only time someone has smoked a Black & Mild cigar in a Virginia courtroom at the request of a judge.

He was defending a client in Fairfax who police searched after saying they smelled marijuana during a routine traffic stop. But Zinicola argued in court that it was impossible for the state trooper to smell the drug, wrapped in two layers of plastic wrap in the back seat, over the overpowering scent of the Black & Mild the man was smoking at the time.

The judge, Jane Marum Roush, who would go on to serve a brief term on the Supreme Court of Virginia, was unfamiliar with the product’s smell and invited him to light it, according to a transcript of the hearing.

“This is highly unorthodox but — here, just go ahead,” she said.

Zinicola wafted the smoke toward Roush, who ultimately agreed — the trooper couldn’t have actually smelled marijuana over the cigar’s overpowering aroma.

The first resort-based medicinal cannabis dispensary in Jamaica, HedoWeedo, has opened in Negril with high-end cannabis making its way to the island's west coast.

HedoWeedo, which is independently owned and operated, is located within the Hedonism II resort, but not part of the all-inclusive experience. Hedonism II, a pioneer in Jamaica's hospitality industry, says it is thrilled to welcome HedoWeedo within its locale.

Curated by the longest-running dispensary on Denver's famous Green Mile, HedoWeedo specialises in high-end craft cannabis with products ranging from joints to flowers to oils, all locally cultivated by licensed farmers.

HedoWeedo says its mission is to promote the well-being of its customers by providing expert, personalised service, while offering a safe and comfortable environment to enjoy top-quality Jamaican cannabis.

HedoWeedo clients, who may include but are not limited to Hedonism II resort guests, will enjoy a unique, world-class dispensary, which the company promises “will far exceed the expectations of novice and experienced medicinal cannabis users alike”.